<scp>Guillain‐Barre</scp> syndrome associated with <scp>COVID</scp>‐19 infection: A case series
Ayman Ahmed, Rahba El‐Amin, Ahmed Musa, Muaz Abdellatif Mohammed Elsayed, Lamis Ahmed Fahal, Eiman Siddig Ahmed, Yousif Ali, Ipyn Eric Nebie, Nouh Saad Mohamed, Jakob Zinsstag, Emmanuel Edwar Siddig, Sarah El-Sadig
Abstract
In this communication, we reported a series of six patients presented with Guillain-Barré syndrome that associated with COVID-19 infection, which was confirmed with RT-PCR. Here we discuss the laboratory investigation and case management, as well as clinical presentation and outcome of each case. The current report demonstrated the first case series of COVID-19-associated GBS-cases in Sudan.
Topics & Concepts
Guillain-Barre syndromeMedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Presentation (obstetrics)2019-20 coronavirus outbreakSeries (stratigraphy)VirologyPediatricsInternal medicineSurgeryDiseaseInfectious disease (medical specialty)BiologyOutbreakPaleontologyLong-Term Effects of COVID-19Peripheral Neuropathies and DisordersInfectious Encephalopathies and Encephalitis